# Regulatory Compliance in Gastroenterology

## Overview

Regulatory compliance in the gastroenterology domain encompasses federal and state
regulations that govern patient data protection, medical device oversight, clinical
documentation requirements, and reimbursement rules. These regulatory requirements
directly shape the domain model by imposing constraints on data handling, audit
trails, documentation completeness, and reporting obligations. In DDD terms,
regulatory requirements are domain constraints that must be enforced by aggregates,
validated by value objects, and tracked by domain events.

## HIPAA (Health Insurance Portability and Accountability Act)

### Privacy Rule Impact on Domain Model

HIPAA's Privacy Rule governs the use and disclosure of protected health information
(PHI). In the gastroenterology domain, every aggregate that contains patient-
identifiable data must enforce access controls. The domain model addresses this by:

- Requiring authenticated and authorized access to all patient-related aggregates.
- Enforcing minimum necessary data disclosure in domain events that cross bounded
  context boundaries.
- Tracking all access to patient data through audit domain events.
- Supporting patient rights to access, amend, and request restriction of their data.

### Security Rule Impact on Domain Model

HIPAA's Security Rule requires safeguards for electronic PHI. While infrastructure
implementation details are outside the domain model, the model enforces:

- Immutability of clinical records once signed (amendment creates new records).
- Audit trail through domain events for all data creation, modification, and access.
- Data integrity validation through value object self-validation.

### Breach Notification

The domain model supports breach notification requirements by maintaining comprehensive
event logs that can reconstruct what data was accessed, by whom, and when. The event-
driven architecture provides a natural audit trail.

## FDA (Food and Drug Administration)

### Medical Device Regulation

Endoscopic equipment and capsule endoscopy devices are FDA-regulated medical devices.
The Endoscopic Procedures Context must:

- Track device identification (UDI - Unique Device Identifier) for procedures.
- Document adverse events associated with device use.
- Support post-market surveillance reporting.

The EndoscopicProcedure aggregate includes device identification fields and the
ComplicationOccurred domain event captures adverse device events for FDA reporting.

### Drug Safety and Biologic Monitoring

The Inflammatory Disease Context manages biologic therapies that are FDA-regulated
drugs. The TherapyRegimen aggregate must:

- Track lot numbers and administration details for biologic agents.
- Document adverse drug reactions.
- Support Risk Evaluation and Mitigation Strategy (REMS) program requirements where
  applicable.
- Maintain therapeutic drug monitoring records as required by prescribing information.

## CMS (Centers for Medicare and Medicaid Services)

### Quality Reporting

CMS quality programs require reporting of specific clinical quality measures. The
gastroenterology domain model supports several measures:

- Screening colonoscopy: documentation of adenoma detection rate, cecal intubation
  rate, and follow-up recommendation appropriateness.
- IBD management: documentation of steroid-sparing therapy use, disease activity
  assessment frequency, and preventive care compliance.
- Hepatitis C: documentation of treatment initiation and sustained virologic response.

Quality metrics are tracked within the relevant bounded contexts and made available
through read-model projections for reporting purposes.

### Documentation Requirements for Reimbursement

CMS requires specific documentation elements for procedure reimbursement. The
Endoscopic Procedures Context ensures that procedure documentation includes:

- Clinical indication with supporting diagnosis code.
- Informed consent documentation.
- Procedure description with findings, interventions, and specimens.
- Appropriate CPT and ICD-10 coding.
- Pathology follow-up documentation.

The EndoscopicProcedure aggregate's completeness invariant enforces that all CMS-
required documentation elements are present before a procedure record can be finalized.

## State Regulations

### Informed Consent

State laws govern informed consent requirements for endoscopic procedures. The
Endoscopic Procedures Context must support state-specific consent documentation
requirements, including specific risk disclosures, cooling-off periods, and witness
requirements. The consent documentation within the EndoscopicProcedure aggregate
is configurable to state-specific requirements.

### Mandatory Reporting

Certain diagnoses (e.g., hepatitis B and C) have mandatory reporting requirements
to state health departments. The Hepatology Context raises domain events for
reportable diagnoses that can be consumed by public health reporting integration.

## Regulatory Impact on Domain Design

### Audit Trail Requirements

Every bounded context maintains domain events that serve as an immutable audit trail.
Clinical documentation, once signed, cannot be modified; amendments create new entries
referencing the original. This is enforced at the aggregate level through state
transition rules.

### Data Retention

Clinical records must be retained for periods specified by federal and state law
(typically 7-10 years for adults, longer for minors). The repository layer implements
retention policies, but the domain model enforces that records are never permanently
deleted during the retention period.

### Compliance Validation

Domain services can validate that documentation meets regulatory requirements before
finalization. The QualityMetricsCalculationService verifies that required quality
indicators are documented. The aggregate's completeness invariant ensures that
regulatory documentation requirements are satisfied.

### Interoperability Requirements

CMS and ONC (Office of the National Coordinator) interoperability rules require that
patient data be available through standardized APIs. The anti-corruption layers and
published language contracts support FHIR-based data exchange while maintaining
domain model integrity.

## References

- Evans, E. (2003). *Domain-Driven Design*. Addison-Wesley.
- Vernon, V. (2013). *Implementing Domain-Driven Design*. Addison-Wesley.
- Khononov, V. (2021). *Learning Domain-Driven Design*. O'Reilly Media.
- HIPAA Privacy Rule, 45 CFR Parts 160, 164 Subparts A, E.
- HIPAA Security Rule, 45 CFR Parts 160, 164 Subparts A, C.
- FDA 21 CFR Part 820 Quality System Regulation.
- CMS Merit-based Incentive Payment System (MIPS) quality measures.
- ONC 21st Century Cures Act Final Rule on Interoperability.
